Revealing new product video from Livongo digital therapeutics competitor, DarioHealth

July 24, 2020

Diabetes management on a smartphone along with price is how Dario intends to compete with Livongo

DarioHealth (Nasdaq: DRIO) seems to be intent to maximize the advantages it maintains over Livongo , including lower cost and the use of a smartphone rather than a separate device.


Cost to economy and society of chronic illness like diabetes is
July 28, 2020
Former Bayer and Ascensia diabetes care chief medical officer, Dr. David Simmons, joins DarioHealth CMO and president in a detailed discussion on how to finally rollback pervasive diabetes and chronic illness using digital therapeutics like Dario.